From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.
The investment firm reported a purchase of $41,874,150 in EyePoint Pharmaceuticals $EYPT.
MFS Investment Management filed a 13G for QIAGEN N.V. $QGEN revealing an increase in ownership from 9.14% to 10.50%.
Here’s The Hot Corner, with data through December 6, 2023:
The CEO and the CFO of MGP Ingredients $MGPI filed Form 4s revealing a purchase of $109,694 between the two.
In the options market, there was bullish flow in Infinera Corporation $INFN, Five9 Inc $FIVN, and Compania de Minas Buenaventura S.A.A. $BVN.
Stay tuned. We’ll be back on Friday with more insider activity.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team